x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Two Onc Docs

This is Sam and Karine, and we are Two Onc Docs! We both graduated from our Heme/Onc fellowships in 2021 and became board certified in both Hematology and Oncology. Our mission with Two Onc Docs is to create short board review episodes that you can listen to on your drive to work, while you make your morning coffee, or between pages on call. This is intended to be a supplement to other established board studying resources for busy trainees. *This podcast is intended to be an educational resource for

health & fitness medicine

All Episodes

16:22

Hemophilia 2024 UPDATE

Two Onc Docs ·

2024/08/19

This week’s episode will be repeating our episode on hemophilias with some updates. We will go over all high yield facts regarding both hemophilia A and B for your boards and end with a little bit about acquired hemophilias.

en-us

10:09

ASCO 2024 Plenary: NADINA Trial Neoadjuvant Ipi/Nivo...

Two Onc Docs ·

2024/08/12

This week’s episode will be discussing updates from ASCO 2024 next with the practice changing NADINA trial presented on the Sunday of ASCO by Dr. Christian Blank during the plenary sessions: A multicenter, randomized, phase 3 trial comparing the efficacy of neoadjuvant ipilimumab plus nivolumab with standard adjuvant nivolumab in macroscopic resectable stage III melanoma. We discuss the staging and prior standard of treatment for locally advanced melanoma, key findings from NADINA, and ...

en-us

14:47

Oncology for the IM Board Tips 2024

Two Onc Docs ·

2024/08/05

Today’s episode is a continuation on fast facts for the IM Board review focusing on the oncology questions. Another 6% of the certifying ABIM test is oncology. While we can’t cover ALL of oncology in just 10 minutes, here are 10 high yield concepts/facts/vignettes you should know walking into your IM Boards.

en-us

16:49

Hematology for the IM Board Tips 2024

Two Onc Docs ·

2024/07/29

Today’s episode focuses on what you need to know to ace the hematology questions for your 2024 IM boards. 6% of the ABIM exam is hematology which includes erythrocyte, leukocyte and platelet disorders, coagulation disorders, transfusion medicine, and heme malignancies. We discuss some common vignettes & high yield points.

en-us

12:34

Infusion Reactions

Two Onc Docs ·

2024/07/22

This week’s episode will be focusing on infusion reactions - one of the most common calls we get as heme/onc fellows and high yield facts for new fellows as well as boards. We will go over the important details on mechanisms of infusion reaction, class of drugs that most commonly cause infusion reactions, treatment for infusion reactions, and when/how to re-challenge.

en-us

12:27

Oncologic Emergencies

Two Onc Docs ·

2024/07/15

This week’s episode will be focusing on common topics both for new fellows & residents. We will go over the important details on some clinically important oncologic emergencies including brain metastases, hypercalcemia, cord compression and SVC syndrome.

en-us

12:26

ASCO 2024 Plenary: ADRIATIC Trial in Limited Stage...

Two Onc Docs ·

2024/07/08

This week’s episode will discuss updates from ASCO 2024 next with the practice changing ADRIATIC trial presented by Dr. Spigel during the plenary: Durvalumab as consolidation treatment for patients with limited-stage small-cell lung cancer (LS-SCLC).

en-us

27:48

Tips for New Doctors (& A Few For New Attendings)

Two Onc Docs ·

2024/07/01

In light of the new academic year today, we are so excited for this special episode, hosting Dr Shikha Jain, who is the founder of Women in Medicine & a GI oncologist, & involved with ASCO Women's Networking Center. She shares some of her tips for new doctors, and a few for new attendings.

en-us

17:29

Acute Myeloid Leukemia (AML) 2024 x Dr. Catherine Lai...

Two Onc Docs ·

2024/06/24

Today’s episode is an update on AML (acute myeloid leukemia). In Part 2 we discuss the treatment options for first-line, as well as relapsed/refractory disease. We are so honored to have Dr. Catherine Lai here with us who is Associate Professor and Physician Leader of the Leukemia Clinical Research Unit at UPenn.

en-us

25:17

Acute Myeloid Leukemia (AML) 2024 x Dr. Catherine Lai...

Two Onc Docs ·

2024/06/19

Today’s episode is an update on AML (acute myeloid leukemia). In Part 1 we discuss the usual presentation, diagnostic work-up, and updates on the classification of AMLs. We are so honored to have Dr. Catherine Lai here with us who is Associate Professor and Physician Leader of the Leukemia Clinical Research Unit at UPenn.

en-us

12:15

ASCO 2024 Plenary: LAURA Trial in Unresectable Stage...

Two Onc Docs ·

2024/06/10

This week’s episode will be discussing updates from the ASCO 2024 annual meeting starting with the practice changing LAURA trial: Osimertinib after definitive chemoradiotherapy in patients with unresectable stage III epidermal growth factor receptor-mutated NSCLC: Primary results of the phase 3 LAURA study presented by Dr. Ramalingam.

en-us

23:43

Metastatic Melanoma 2024 x Dr. Mike Atkins Part 2

Two Onc Docs ·

2024/06/03

Today’s episode is updating what you need to know regarding the treatment of metastatic melanoma. We are so honored to have Dr. Michael Atkins here with us today, who is the first author of the practice changing DREAMseq trial, and provides his expertise on this important topic.

en-us

21:16

Localized Melanoma 2024 x Dr. Mike Atkins Part 1

Two Onc Docs ·

2024/05/27

Today’s episode is a 2024 update on what to know regarding the risk factors, diagnostic work-up, staging and treatment of localized melanoma. We are so honored to have Dr. Michael Atkins here with us today who is deputy director of the Georgetown Lombardi Comprehensive Cancer Center . He is an internationally recognized expert in the management of patients with high-risk and metastatic melanoma or kidney cancer.

en-us

9:39

Genetic Syndromes Part 2

Two Onc Docs ·

2024/05/20

This week’s episode will be focusing on the second part of genetic syndromes with risk of malignancy. Last week we covered Li Fraumeni, Lynch, FAP, BRCA ½ and Cowdens. This week we are going to cover the syndromes associated with RCC as well as MEN 1 and 2 and a few others.

en-us

12:11

Genetic Syndromes Part 1

Two Onc Docs ·

2024/05/13

This week’s episode will be focusing on genetic syndromes with increased risk of malignancies. In Part 1 we discuss Li-Fraumeni, Lynch Syndrome, FAP, BRCA 1 and 2, and Cowden's syndrome.

en-us

29:28

Metastatic Kidney Cancer x Uromigos 2024 UPDATES...

Two Onc Docs ·

2024/05/06

Today’s episode we will cover 2024 updates for metastatic renal cell carcinoma. We will discuss risk categories, treatment options, and variant histologies. We are so excited to have Dr. Tom Powles and Dr. Brian Rini from the urologic oncology podcast Uromigos sharing their expertise on today's episode as well!

en-us

16:58

Localized Kidney Cancer x Uromigos 2024 UPDATES (Part 1)

Two Onc Docs ·

2024/04/29

en-us

24:44

Testicular Cancer 2024 x Dr. Larry Einhorn Part 2...

Two Onc Docs ·

2024/04/22

en-us

31:28

Testicular Cancer 2024 x Dr. Larry Einhorn Part 1...

Two Onc Docs ·

2024/04/15

en-us

13:40

Hematopoietic Growth Factors

Two Onc Docs ·

2024/04/08

en-us

178 results

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

The Dry Eye Treatment PODCAST

Dry Eye Treatment

Différent et alors ?

PATRICK SULAY

Kyle Kingsbury Podcast

Kyle Kingsbury

The Real Weight Loss Coach

Matty Lansdown